Nawrocka-Millward, S.; Biegus, J.; Hurkacz, M.; Guzik, M.; Rosiek-Biegus, M.; Jankowska, E.A.; Ponikowski, P.; Zymliński, R.
Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure. Biomolecules 2021, 11, 1701.
https://doi.org/10.3390/biom11111701
AMA Style
Nawrocka-Millward S, Biegus J, Hurkacz M, Guzik M, Rosiek-Biegus M, Jankowska EA, Ponikowski P, Zymliński R.
Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure. Biomolecules. 2021; 11(11):1701.
https://doi.org/10.3390/biom11111701
Chicago/Turabian Style
Nawrocka-Millward, Sylwia, Jan Biegus, Magdalena Hurkacz, Mateusz Guzik, Marta Rosiek-Biegus, Ewa Anita Jankowska, Piotr Ponikowski, and Robert Zymliński.
2021. "Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure" Biomolecules 11, no. 11: 1701.
https://doi.org/10.3390/biom11111701
APA Style
Nawrocka-Millward, S., Biegus, J., Hurkacz, M., Guzik, M., Rosiek-Biegus, M., Jankowska, E. A., Ponikowski, P., & Zymliński, R.
(2021). Differences in the Biomarker Profile of De Novo Acute Heart Failure versus Decompensation of Chronic Heart Failure. Biomolecules, 11(11), 1701.
https://doi.org/10.3390/biom11111701